New concept for the separation of an anomeric mixture of α/β-D-nucleosides through regioselective enzymatic acylation or hydrolysis processes

Journal of Organic Chemistry

Volumn 71, Issue 26, 2006, Pages 9765-9771

  García, Javier ^a   Díaz Rodríguez, Alba ^a   Fernández, Susana ^a   Sanghvi, Yogesh S ^b   Ferrero, Miguel ^a   Gotor, Vicente ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b RASAYAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION; CATALYST ACTIVITY; DERIVATIVES; ENZYME KINETICS; HYDROLYSIS; INDUSTRIAL WASTES; SYNTHESIS (CHEMICAL);

ANOMERIC MIXTURES; REGIOSELECTIVITY; THYMIDINE DERIVATIVES;

NUCLEIC ACIDS;

ARABINONUCLEOSIDE; NUCLEOSIDE DERIVATIVE; THYMIDINE DERIVATIVE; TRIACYLGLYCEROL LIPASE;

ACYLATION; ARTICLE; BURKHOLDERIA CEPACIA; ENZYME MECHANISM; HYDROLYSIS; QUANTUM YIELD; REACTION ANALYSIS; SEPARATION TECHNIQUE; STEREOCHEMISTRY; SYNTHESIS; TECHNIQUE;

ACYLATION; CARBOHYDRATE CONFORMATION; HYDROLYSIS; NUCLEOSIDES; STEREOISOMERISM;

EID: 33845942769     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo062033o     Document Type: Article

References (67)

1. (a) Frontiers in Nucleosides and Nucleic Acids; Schinazi, R. F., Liotta, D. C., Eds.; IHL Press: Georgia, 2004 .
2. (b) Stephens, A. C.; Rivers, R. P. A. Curr. Opin. Mol. Ther. 2003, 5, 118-122.
3. (c) Leumann, C. J. Bioorg. Med. Chem. 2002, 10, 841-854.
4. (d) Opalinska, J. B.; Gewirtz, A. M. Nat. Rev. Drug Discovery 2002, 1, 503-513.
5. (e) Recent Advances in Nucleosides: Chemistry and Chemotherapy; Chu, C. K., Ed.; Elsevier Science: New York, 2002.
6. (f) Antisense Drug Technology Principles, Stategies and Applications; Crooke, S. T., Ed.; Marcel Dekker: New York, 2001.
7. (g) Uhlmann, E. Curr. Opin. Drug Discovery Dev. 2000, 3, 203-213.
8. (h) Sanghvi, Y. S. In Comprehensive Natural Products Chemistry; Kool, E. T., Ed.; Elsevier: Amsterdam, 1999; Vol. 7, Chapter 7, pp 285-311 and references cited therein.
9. (i) Nucleosides Nucleotides as Antitumor and Antiviral Agents; Chu, C. K., Baker, D. C., Eds.; Plenum Press: New York, 1993.
10. LePage, G. A.; Khaliq, A. Cancer Treat. Rep. 1979, 63, 53-57.
11. Acton, E. M.; Goerner, R. N.; Uh, H. S.; Ryan, K. J.; Henry, D. W. J. Med. Chem. 1979, 22, 518-525.
12. (a) Bretner, M.; Balinska, M.; Krawiec, K.; Kierdaszuk, B.; Shugar, D.; Kulikowski, T. Nucleosides Nucleotides 1995, 14, 657-660.
13. (b) Bretner, M.; Kulikowski, T.; Dzik, J. M.; Balinska, M.; Rode, W.; Shugar, D. J. Med. Chem. 1993, 36, 3611-3617.
14. (a) Kierdaszuk, B.; Krawiec, K.; Kazimierczuk, Z.; Jacobsson, U.; Johansson, N. G.; Munch-Petersen, B.; Eriksson, S.; Shugar, D. Nucleosides Nucleotides 1999, 18, 1883-1903.
15. (b) Armstrong, V. W.; Sternbach, H.; Eckstein, F. Biochemistry 1976, 15, 2086-2091.
16. Van Daele, I.; Munier-Lehmann, H.; Vandamme, S.; Bultinck, P.; Van Calenbergh, S. IRT-XVII Nucleosides, Nucleotides and Nucleic Acids, September 3-7, 2006, Bern, Switzerland, PO124.
17. (a) Michel, T.; Debart, F.; Heitz, F.; Vasseur, J.-J. ChemBioChem 2005, 6, 1254-1262.
18. (b) Michel, T.; Martinand-Mari, C.; Debart, F.; Lebleu, B.; Robbins, I.; Vasseur, J.-J. Nucleic Acids Res. 2003, 31, 5282-5290.
19. (c) Laurent, A.; Naval, M.; Debart, F.; Vasseur, J.-J.; Rayner, B. Nucleic Acids Res. 1999, 27, 4151-4159.
20. (d) Abdel Aleem, A. A. H.; Larsen, E.; Pedersen, E. B. Tetrahedron 1995, 51, 7867-7876.
21. (e) Rayner, B.; Malvy, C.; Paoletti, J.; Lebleu, B.; Paoletti, C.; Imbach, J.-L. In Topics in Molecular and Structural Biology; Cohen, J. S., Ed.; MacMillan Press: London, 1989; Vol. 12, pp 119-136.
22. Lavignon, M.; Tounekti, N.; Rayner, B.; Imbach, J.-L.; Keith, G.; Paoletti, J.; Malvy, C. Antisense Res. Dev. 1992, 2, 315-324.
23. (a) Shoda, K.; Wada, T.; Sekine, M. Nucleosides Nucleotides 1998, 17, 2199-2210.
24. (b) Shinozuka, K.; Yamada, N.; Nakamura, A.; Ozaki, H.; Sawai, H. Bioorg. Med. Chem. Lett. 1996, 6, 1843-1848.
25. (c) Sawai, H.; Nakamura, A.; Hayashi, H.; Shinozuka, K. Nucleosides Nucleotides 1994, 13, 1647-1654.
26. (d) Janardhanam, S.; Nambiar, K. P. Tetrahedron Lett. 1994, 35, 3657-3660.
27. (c) Sugimura, H.; Sujino, K.; Osumi, K. Nucleic Acids Symp. Ser. 1992, 27, 111-112.
28. (f) Aoyama, H. Bull. Chem. Soc. Jpn. 1987, 60, 2073-2077.
29. (a) Sato, Y.; Tateno, G.; Seio, K.; Sekine, M. Eur. J. Org. Chem. 2002, 87-93.
30. (b) Sato, Y.; Tateno, G.; Seio, K.; Sekine, M. Tetrahedron Lett. 2002, 43, 3251-3254.
31. (c) Yamaguchi, T.; Saneyoshi, M. Chem. Pharm. Bull. 1984, 32, 1441-1450.
32. (d) Vorbrüggen, H.; Krolikiewicz, K.; Bennua, B. Chem. Ber. 1981, 114, 1234-1255.
33. (a) Lavandera, I.; Fernández, S.; Magdalena, J.; Ferrero, M.; Jarjap, H.; Savile, C. K.; Kazlauskas, R. J.; Gotor, V. ChemBioChem 2006, 7, 693-698.
34. (b) Díaz-Rodríguez, A.; Fernández, S.; Sanghvi, Y. S.; Ferrero, M.; Gotor, V. Org. Process Res. Dev. 2006, 10, 581-587.
35. (c) Lavandera, I.; Fernández, S.; Magdalena, J.; Ferrero, M.; Kazlauskas, R. J.; Gotor, V. ChemBioChem 2005, 6, 1381-1390.
36. (d) Díaz-Rodríguez, A.; Fernández, S.; Lavandera, I.; Ferrero, M.; Gotor, V. Tetrahedron Lett. 2005, 46, 5835-5838.
37. (e) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Tetrahedron Lett. 2004, 45, 1709-1712.
38. (f) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Tetrahedron: Asymmetrv 2003, 14, 3533-3540.
39. (g) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. J. Org. Chem. 2002, 67, 4513-4519.
40. Morís, F.; Gotor, V. Tetrahedron 1993, 49, 10089-10098.
41. Damkjaer, D. L.; Petersen, M.; Wengel, J. Nucleosides Nucleotides 1994, 13, 1801-1807.
42. Van Draanen, N. A.; Koszalka, G. W. Nucleosides Nucleotides 1994, 13, 1679-1693.
43. García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Or8. Lett. 2004, 6, 3759-3762.
44. (a) Protecting Groups; Kocienski, P. J., Ed.; Thieme: New York, 2000; p 338.
45. (b) Protective Groups in Organic Synthesis; Green, T. W., Wuts, P. G. M., Eds.; John Wiley: New York, 1999; p 168.
46. (c) For comprehensive literature, see: Current Protocols in Nucleic Acid Chemistry; Beaucage, S. L., Bergstrom, D. E., Click, G. D., Jones, R. A., Eds.; John Wiley: New York, 1999; Chapter 2.
47. Lavandera, I.; García, J.; Fernández, S.; Ferrera, M.; Gotor, V.; Sanghvi, Y. S. In Current Protocols in Nucleic Acid Chemistry; Beaucage, S. L., Bergstrom, D. E., Glick, G. D., Jones, R. A., Eds.; John Wiley: New York, 2005; Chapters 2.11.1-2.11.36.
48. The α-2′-deoxynucleosides were Purchased from ChemGenes Corporation, Wilmington, MA.
49. The equimolar mixture of the two nucleosides was prepared by mixing the equal weight of α-D-thymidine and β-D-thymidine. A mixture of 1c and 3c was prepared in a similar manner.
50. See Supporting Information for details.
51. Czernecki, S.; Valéry, J.-M. Synthesis 1991, 239-240.
52. (a) Prasad, A. K.; Kumar, V.; Malhotra, S.; Ravikumar, V. T.; Sanghvi, Y. S.; Parmar, V. S. Bioorg. Med. Chem. 2005, 13, 4467-4472.
53. (b) Uzagare, M. C.; Sanghvi, Y. S.; Salunkhe, M. M. Green Chem. 2003, 5, 370-372.
54. (c) Sanghvi, Y. S.; Ravikumar, V. T.; Scozzari, A. N.; Cole, D. L. Pure Appl. Chem. 2001, 73, 175-180.
55. The price of α-thymidine from ChemGenes Corp. is $645/gram.
56. ID Biochem. Inc. Ulsan, Korea (www.idbio.co.kr).
57. CAL-B is available from Novozyme (www.novozymes.com) for $2000/kg, and PSL-C is available from Amano (www.amano-enzyme.co.jp) for $3500/kg.
58. (a) Kalota, A.; Karabon, L.; Swider, C.; Viazovkina, E.; Elzagheid, M.; Damha, M. J.; Gewirtz, A. Nucleic Acids Res. 2006, 34, 451-461.
59. (b) Lok, C.-N.; Viazovkina, E.; Min, K.-L.; Nagy, E.; Wilds, C. J.; Damha, M. J.; Parniak, M. A. Biochemistry 2002, 41, 3457-3467.
60. (c) Damha, M. J.; Wilds, C. J.; Noronha, A.; Brukner, I.; Borkow, G.; Parniak, M. A. J. Am. Chem. Soc. 1998, 121, 12976-12977.
61. Topigen Pharmaceuticals Inc., Montreal, Canada (www.Topigen.com).
62. Elzagheid, M.; Viazovkina, E.; Damha, M. J. In Current Protocols in Nucleic Acid Chemistry; Beaucage, S. L., Bergstrom, D. E., Glick, G. D., Jones, R. A., Eds.; John Wiley: New York, 2005; Chapters 1.7.1-1.7.10.
63. Handbook of Nucleoside Synthesis; Vorbruggen, H., Ruh-Pohlenz, C., Eds.; John Wiley: New York, 2001 and references cited therein.
64. (a) Biocatalysis in the Pharmaceutical and Biotechnology Industries; Patel, R. N., Ed.; CRC Press: Florida, 2006.
65. (b) García-Urdiales, E.; Alfonso, I.; Gotor, V. Chem. Rev. 2005, 105, 313-354.
66. (c) Fernández, S.; Gotor-Fernández, V.; Ferrero, M.; Gotor, V. Curr. Org. Chem. 2002, 6, 453-469.
67. (d) Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319-4397.